Cargando…
Approaching the immunophysiology of steroid resistance
Wang and colleagues have investigated a mechanistic basis for resistance to steroid therapy in systemic lupus erythematosus patients. Their examination reveals significant differences in macrophage migration inhibitory factor (MIF)-dependent expression of IκB, which is a critical cellular regulator...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446475/ https://www.ncbi.nlm.nih.gov/pubmed/22640701 http://dx.doi.org/10.1186/ar3820 |
_version_ | 1782243984576348160 |
---|---|
author | Bucala, Rick |
author_facet | Bucala, Rick |
author_sort | Bucala, Rick |
collection | PubMed |
description | Wang and colleagues have investigated a mechanistic basis for resistance to steroid therapy in systemic lupus erythematosus patients. Their examination reveals significant differences in macrophage migration inhibitory factor (MIF)-dependent expression of IκB, which is a critical cellular regulator of the broadly proinflammatory transcription factor NF-κB. Their studies also suggest that MIF may be a clinically useful biomarker in systemic lupus erythematosus and support the therapeutic targeting of MIF as a means to reduce clinical steroid resistance. |
format | Online Article Text |
id | pubmed-3446475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34464752012-11-18 Approaching the immunophysiology of steroid resistance Bucala, Rick Arthritis Res Ther Editorial Wang and colleagues have investigated a mechanistic basis for resistance to steroid therapy in systemic lupus erythematosus patients. Their examination reveals significant differences in macrophage migration inhibitory factor (MIF)-dependent expression of IκB, which is a critical cellular regulator of the broadly proinflammatory transcription factor NF-κB. Their studies also suggest that MIF may be a clinically useful biomarker in systemic lupus erythematosus and support the therapeutic targeting of MIF as a means to reduce clinical steroid resistance. BioMed Central 2012 2012-05-18 /pmc/articles/PMC3446475/ /pubmed/22640701 http://dx.doi.org/10.1186/ar3820 Text en Copyright ©2012 BioMed Central Ltd |
spellingShingle | Editorial Bucala, Rick Approaching the immunophysiology of steroid resistance |
title | Approaching the immunophysiology of steroid resistance |
title_full | Approaching the immunophysiology of steroid resistance |
title_fullStr | Approaching the immunophysiology of steroid resistance |
title_full_unstemmed | Approaching the immunophysiology of steroid resistance |
title_short | Approaching the immunophysiology of steroid resistance |
title_sort | approaching the immunophysiology of steroid resistance |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446475/ https://www.ncbi.nlm.nih.gov/pubmed/22640701 http://dx.doi.org/10.1186/ar3820 |
work_keys_str_mv | AT bucalarick approachingtheimmunophysiologyofsteroidresistance |